2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
DE10025609A1
Transfection system
DE19913333A1
Hyperforin as a cytostatic
DE19900578C1
Method of spatially resolved magnetic resonance spectroscopy
DE19854446A1
Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections
DE19853066A1
Use of hyaluronic acid fragments in vaccine production, especially for cancer treatment
DE19849348A1
Identification and/or sequencing of an unknown DNA or RNA sequence adjacent to a known DNA or RNA region comprises linker-mediated PCR following amplification by linear PCR
DE19849044A1
New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies
DE19839113A1
Use of hyaluronic acid fragments in vaccine production, especially for cancer treatment
DE19828671A1
Container with cryopreserved biological material
DE19814950A1
Nuclear magnetic resonance process for patient examinations, especially for brain excitation
DE19802540C1
Process for concentration of dendritic cells
DE19751062A1
4-substituted 2-pyrrolidinone derivatives to reduce extracellular glutamate levels
DE19750214A1
Process for generating nuclear spin spectroscopic signals by spatial modulation of z-magnetization
WO9806825A1
Artificial rheumatic pannus tissues and diagnostic method for detecting rheumatoid arthritis
DE19731879A1
Intramedullary splint system for long bones
DE19716098A1
Fibroblasts containing a foreign gene composition for treating wounds
DE19707493C1
Nucleic acid construct for trans-gene expression
DE19700114C1
Handle part of an endoscopic instrument
DE19700113A1
Device for lifting organ parts for feeding through surgical engagement device into rectal region of human body
